메뉴 건너뛰기




Volumn 7, Issue 4, 2012, Pages

The role of natural killer (NK) cells and nk cell receptor polymorphisms in the assessment of HIV-1 neutralization

Author keywords

[No Author keywords available]

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; MONOCLONAL ANTIBODY; NATURAL KILLER CELL RECEPTOR; POLYCLONAL ANTIBODY; FC RECEPTOR; FCGR3A PROTEIN, HUMAN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS1; NEUTRALIZING ANTIBODY;

EID: 84859567727     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029454     Document Type: Article
Times cited : (20)

References (59)
  • 2
    • 34848908400 scopus 로고    scopus 로고
    • A Phase 1/2 Comparative Vaccine Trial of the Safety and Immunogenicity of a CRF01_AE (Subtype E) Candidate Vaccine: ALVAC-HIV (vCP1521) Prime With Oligomeric gp160 (92TH023/LAI-DID) or Bivalent gp120 (CM235/SF2) Boost
    • Thongcharoen P, Suriyanon V, Paris RM, Khamboonruang C, de Souza MS, et al. (2007) A Phase 1/2 Comparative Vaccine Trial of the Safety and Immunogenicity of a CRF01_AE (Subtype E) Candidate Vaccine: ALVAC-HIV (vCP1521) Prime With Oligomeric gp160 (92TH023/LAI-DID) or Bivalent gp120 (CM235/SF2) Boost. J Acquir Immune Defic Syndr 46: 48-55.
    • (2007) J Acquir Immune Defic Syndr , vol.46 , pp. 48-55
    • Thongcharoen, P.1    Suriyanon, V.2    Paris, R.M.3    Khamboonruang, C.4    de Souza, M.S.5
  • 4
    • 0042315405 scopus 로고    scopus 로고
    • Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults
    • Pitisuttithum P, Nitayaphan S, Thongcharoen P, Khamboonruang C, Kim J, et al. (2003) Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults. J Infect Dis 188: 219-227.
    • (2003) J Infect Dis , vol.188 , pp. 219-227
    • Pitisuttithum, P.1    Nitayaphan, S.2    Thongcharoen, P.3    Khamboonruang, C.4    Kim, J.5
  • 5
    • 69149083668 scopus 로고    scopus 로고
    • Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?
    • Stamatatos L, Morris L, Burton DR, Mascola JR, (2009) Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine? Nat Med 15: 866-870.
    • (2009) Nat Med , vol.15 , pp. 866-870
    • Stamatatos, L.1    Morris, L.2    Burton, D.R.3    Mascola, J.R.4
  • 6
    • 0021840491 scopus 로고
    • HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex
    • Robert-Guroff M, Brown M, Gallo RC, (1985) HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex. Nature 316: 72-74.
    • (1985) Nature , vol.316 , pp. 72-74
    • Robert-Guroff, M.1    Brown, M.2    Gallo, R.C.3
  • 7
    • 0023111153 scopus 로고
    • Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells
    • Rook AH, Lane HC, Folks T, McCoy S, Alter H, et al. (1987) Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells. J Immunol 138: 1064-1067.
    • (1987) J Immunol , vol.138 , pp. 1064-1067
    • Rook, A.H.1    Lane, H.C.2    Folks, T.3    McCoy, S.4    Alter, H.5
  • 8
    • 0034958413 scopus 로고    scopus 로고
    • Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells
    • Forthal DN, Landucci G, Daar ES, (2001) Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells. J Virol 75: 6953-6961.
    • (2001) J Virol , vol.75 , pp. 6953-6961
    • Forthal, D.N.1    Landucci, G.2    Daar, E.S.3
  • 9
    • 33744916994 scopus 로고    scopus 로고
    • Nonneutralizing antibodies are able to inhibit human immunodeficiency virus type 1 replication in macrophages and immature dendritic cells
    • Holl V, Peressin M, Decoville T, Schmidt S, Zolla-Pazner S, et al. (2006) Nonneutralizing antibodies are able to inhibit human immunodeficiency virus type 1 replication in macrophages and immature dendritic cells. J Virol 80: 6177-6181.
    • (2006) J Virol , vol.80 , pp. 6177-6181
    • Holl, V.1    Peressin, M.2    Decoville, T.3    Schmidt, S.4    Zolla-Pazner, S.5
  • 10
    • 0025204815 scopus 로고
    • Neutralization of human immunodeficiency virus type 1 by complement occurs by viral lysis
    • Spear GT, Sullivan BL, Landay AL, Lint TF, (1990) Neutralization of human immunodeficiency virus type 1 by complement occurs by viral lysis. J Virol 64: 5869-5873.
    • (1990) J Virol , vol.64 , pp. 5869-5873
    • Spear, G.T.1    Sullivan, B.L.2    Landay, A.L.3    Lint, T.F.4
  • 11
    • 0033952103 scopus 로고    scopus 로고
    • Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection
    • Baba TW, Liska V, Hofmann-Lehmann R, Vlasak J, Xu W, et al. (2000) Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med 6: 200-206.
    • (2000) Nat Med , vol.6 , pp. 200-206
    • Baba, T.W.1    Liska, V.2    Hofmann-Lehmann, R.3    Vlasak, J.4    Xu, W.5
  • 12
    • 0037029924 scopus 로고    scopus 로고
    • Passive transfer studies to elucidate the role of antibody-mediated protection against HIV-1
    • Mascola JR, (2002) Passive transfer studies to elucidate the role of antibody-mediated protection against HIV-1. Vaccine 20: 1922-1925.
    • (2002) Vaccine , vol.20 , pp. 1922-1925
    • Mascola, J.R.1
  • 13
    • 0033951746 scopus 로고    scopus 로고
    • Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
    • Mascola JR, Stiegler G, VanCott TC, Katinger H, Carpenter CB, et al. (2000) Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med 6: 207-210.
    • (2000) Nat Med , vol.6 , pp. 207-210
    • Mascola, J.R.1    Stiegler, G.2    VanCott, T.C.3    Katinger, H.4    Carpenter, C.B.5
  • 14
    • 0345166103 scopus 로고    scopus 로고
    • Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: implications for HIV-1 vaccine development
    • Nishimura Y, Igarashi T, Haigwood NL, Sadjadpour R, Donau OK, et al. (2003) Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: implications for HIV-1 vaccine development. Proc Natl Acad Sci U S A 100: 15131-15136.
    • (2003) Proc Natl Acad Sci U S A , vol.100 , pp. 15131-15136
    • Nishimura, Y.1    Igarashi, T.2    Haigwood, N.L.3    Sadjadpour, R.4    Donau, O.K.5
  • 15
    • 0034864776 scopus 로고    scopus 로고
    • Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro
    • Parren PW, Marx PA, Hessell AJ, Luckay A, Harouse J, et al. (2001) Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro. J Virol 75: 8340-8347.
    • (2001) J Virol , vol.75 , pp. 8340-8347
    • Parren, P.W.1    Marx, P.A.2    Hessell, A.J.3    Luckay, A.4    Harouse, J.5
  • 16
    • 0032907674 scopus 로고    scopus 로고
    • Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys
    • Shibata R, Igarashi T, Haigwood N, Buckler-White A, Ogert R, et al. (1999) Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys. Nat Med 5: 204-210.
    • (1999) Nat Med , vol.5 , pp. 204-210
    • Shibata, R.1    Igarashi, T.2    Haigwood, N.3    Buckler-White, A.4    Ogert, R.5
  • 17
    • 77957820631 scopus 로고    scopus 로고
    • Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques
    • Ng CT, Jaworski JP, Jayaraman P, Sutton WF, Delio P, et al. (2010) Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques. Nat Med 16: 1117-1119.
    • (2010) Nat Med , vol.16 , pp. 1117-1119
    • Ng, C.T.1    Jaworski, J.P.2    Jayaraman, P.3    Sutton, W.F.4    Delio, P.5
  • 18
    • 68349160853 scopus 로고    scopus 로고
    • Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques
    • Hessell AJ, Poignard P, Hunter M, Hangartner L, Tehrani DM, et al. (2009) Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques. Nat Med 15: 951-954.
    • (2009) Nat Med , vol.15 , pp. 951-954
    • Hessell, A.J.1    Poignard, P.2    Hunter, M.3    Hangartner, L.4    Tehrani, D.M.5
  • 20
    • 23244467373 scopus 로고    scopus 로고
    • Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines
    • Mascola JR, D'Souza P, Gilbert P, Hahn BH, Haigwood NL, et al. (2005) Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines. J Virol 79: 10103-10107.
    • (2005) J Virol , vol.79 , pp. 10103-10107
    • Mascola, J.R.1    D'Souza, P.2    Gilbert, P.3    Hahn, B.H.4    Haigwood, N.L.5
  • 21
    • 43249120426 scopus 로고    scopus 로고
    • Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination
    • Polonis VR, Brown BK, Rosa Borges A, Zolla-Pazner S, Dimitrov DS, et al. (2008) Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination. Virology 375: 315-320.
    • (2008) Virology , vol.375 , pp. 315-320
    • Polonis, V.R.1    Brown, B.K.2    Rosa, B.A.3    Zolla-Pazner, S.4    Dimitrov, D.S.5
  • 22
    • 78049255341 scopus 로고    scopus 로고
    • Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC
    • Edmonds TG, Ding H, Yuan X, Wei Q, Smith KS, et al. (2010) Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC. Virology 408: 1-13.
    • (2010) Virology , vol.408 , pp. 1-13
    • Edmonds, T.G.1    Ding, H.2    Yuan, X.3    Wei, Q.4    Smith, K.S.5
  • 23
    • 77951080820 scopus 로고    scopus 로고
    • Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokines
    • Moody MA, Liao HX, Alam SM, Scearce RM, Plonk MK, et al. (2010) Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokines. J Exp Med 207: 763-776.
    • (2010) J Exp Med , vol.207 , pp. 763-776
    • Moody, M.A.1    Liao, H.X.2    Alam, S.M.3    Scearce, R.M.4    Plonk, M.K.5
  • 25
    • 0030175380 scopus 로고    scopus 로고
    • Mechanisms contributing to the neutralization of HIV-1
    • Zolla-Pazner S, (1996) Mechanisms contributing to the neutralization of HIV-1. Immunol Lett 51: 89-93.
    • (1996) Immunol Lett , vol.51 , pp. 89-93
    • Zolla-Pazner, S.1
  • 27
    • 57449101496 scopus 로고    scopus 로고
    • NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection
    • Alter G, Altfeld M, (2009) NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection. J Intern Med 265: 29-42.
    • (2009) J Intern Med , vol.265 , pp. 29-42
    • Alter, G.1    Altfeld, M.2
  • 28
    • 79952132247 scopus 로고    scopus 로고
    • DCs and NK cells: critical effectors in the immune response to HIV-1
    • Altfeld M, Fadda L, Frleta D, Bhardwaj N, (2011) DCs and NK cells: critical effectors in the immune response to HIV-1. Nat Rev Immunol 11: 176-186.
    • (2011) Nat Rev Immunol , vol.11 , pp. 176-186
    • Altfeld, M.1    Fadda, L.2    Frleta, D.3    Bhardwaj, N.4
  • 29
    • 0031765786 scopus 로고    scopus 로고
    • In vitro reduction of virus infectivity by antibody-dependent cell-mediated immunity
    • Forthal DN, Landucci G, (1998) In vitro reduction of virus infectivity by antibody-dependent cell-mediated immunity. J Immunol Methods 220: 129-138.
    • (1998) J Immunol Methods , vol.220 , pp. 129-138
    • Forthal, D.N.1    Landucci, G.2
  • 30
    • 20944444788 scopus 로고    scopus 로고
    • Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines
    • Brown BK, Darden JM, Tovanabutra S, Oblander T, Frost J, et al. (2005) Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines. J Virol 79: 6089-6101.
    • (2005) J Virol , vol.79 , pp. 6089-6101
    • Brown, B.K.1    Darden, J.M.2    Tovanabutra, S.3    Oblander, T.4    Frost, J.5
  • 31
    • 69549105767 scopus 로고    scopus 로고
    • New virologic reagents for neutralizing antibody assays
    • Ochsenbauer C, Kappes JC, (2009) New virologic reagents for neutralizing antibody assays. Curr Opin HIV AIDS 4: 418-425.
    • (2009) Curr Opin HIV AIDS , vol.4 , pp. 418-425
    • Ochsenbauer, C.1    Kappes, J.C.2
  • 32
    • 0026643654 scopus 로고
    • A caution on the use of SIV/HIV gag antigen detection systems in neutralization assays
    • Burns DP, Desrosiers RC, (1992) A caution on the use of SIV/HIV gag antigen detection systems in neutralization assays. AIDS Res Hum Retroviruses 8: 1189-1192.
    • (1992) AIDS Res Hum Retroviruses , vol.8 , pp. 1189-1192
    • Burns, D.P.1    Desrosiers, R.C.2
  • 33
    • 66949161526 scopus 로고    scopus 로고
    • High-throughput genotyping of KIR2DL2/L3, KIR3DL1/S1, and their HLA class I ligands using real-time PCR
    • Koehler RN, Walsh AM, Moqueet N, Currier JR, Eller MA, et al. (2009) High-throughput genotyping of KIR2DL2/L3, KIR3DL1/S1, and their HLA class I ligands using real-time PCR. Tissue Antigens 74: 73-80.
    • (2009) Tissue Antigens , vol.74 , pp. 73-80
    • Koehler, R.N.1    Walsh, A.M.2    Moqueet, N.3    Currier, J.R.4    Eller, M.A.5
  • 34
    • 0034610249 scopus 로고    scopus 로고
    • Construction and biological characterization of infectious molecular clones of HIV-1 subtypes B and E (CRF01_AE) generated by the polymerase chain reaction
    • Salminen MO, Ehrenberg PK, Mascola JR, Dayhoff DE, Merling R, et al. (2000) Construction and biological characterization of infectious molecular clones of HIV-1 subtypes B and E (CRF01_AE) generated by the polymerase chain reaction. Virology 278: 103-110.
    • (2000) Virology , vol.278 , pp. 103-110
    • Salminen, M.O.1    Ehrenberg, P.K.2    Mascola, J.R.3    Dayhoff, D.E.4    Merling, R.5
  • 35
    • 78649448853 scopus 로고    scopus 로고
    • Inhibition of HIV-1 infection of peripheral blood mononuclear cells by a monoclonal antibody that binds to phosphoinositides and induces secretion of beta-chemokines
    • Matyas GR, Wieczorek L, Bansal D, Chenine AL, Sanders-Buell E, et al. (2010) Inhibition of HIV-1 infection of peripheral blood mononuclear cells by a monoclonal antibody that binds to phosphoinositides and induces secretion of beta-chemokines. Biochem Biophys Res Commun 402: 808-812.
    • (2010) Biochem Biophys Res Commun , vol.402 , pp. 808-812
    • Matyas, G.R.1    Wieczorek, L.2    Bansal, D.3    Chenine, A.L.4    Sanders-Buell, E.5
  • 36
    • 0034212296 scopus 로고    scopus 로고
    • A flow cytometric method for measuring neutralization of HIV-1 subtype B and E primary isolates
    • Darden JM, Polonis VR, deSouza MS, Chantakulkij S, Brown AE, et al. (2000) A flow cytometric method for measuring neutralization of HIV-1 subtype B and E primary isolates. Cytometry 40: 141-150.
    • (2000) Cytometry , vol.40 , pp. 141-150
    • Darden, J.M.1    Polonis, V.R.2    deSouza, M.S.3    Chantakulkij, S.4    Brown, A.E.5
  • 37
    • 34248168722 scopus 로고    scopus 로고
    • Recombinant gp120 vaccine-induced antibodies inhibit clinical strains of HIV-1 in the presence of Fc receptor-bearing effector cells and correlate inversely with HIV infection rate
    • Forthal DN, Gilbert PB, Landucci G, Phan T, (2007) Recombinant gp120 vaccine-induced antibodies inhibit clinical strains of HIV-1 in the presence of Fc receptor-bearing effector cells and correlate inversely with HIV infection rate. J Immunol 178: 6596-6603.
    • (2007) J Immunol , vol.178 , pp. 6596-6603
    • Forthal, D.N.1    Gilbert, P.B.2    Landucci, G.3    Phan, T.4
  • 38
    • 33750802673 scopus 로고    scopus 로고
    • Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands
    • Jennes W, Verheyden S, Demanet C, Adje-Toure CA, Vuylsteke B, et al. (2006) Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. J Immunol 177: 6588-6592.
    • (2006) J Immunol , vol.177 , pp. 6588-6592
    • Jennes, W.1    Verheyden, S.2    Demanet, C.3    Adje-Toure, C.A.4    Vuylsteke, B.5
  • 40
    • 2942536200 scopus 로고    scopus 로고
    • Polymorphism of Fc receptor IIa for IgG in infants is associated with susceptibility to perinatal HIV-1 infection
    • Brouwer KC, Lal RB, Mirel LB, Yang C, van Eijk AM, et al. (2004) Polymorphism of Fc receptor IIa for IgG in infants is associated with susceptibility to perinatal HIV-1 infection. AIDS 18: 1187-1194.
    • (2004) AIDS , vol.18 , pp. 1187-1194
    • Brouwer, K.C.1    Lal, R.B.2    Mirel, L.B.3    Yang, C.4    van Eijk, A.M.5
  • 41
    • 33144458585 scopus 로고    scopus 로고
    • Genetic association of the antiviral restriction factor TRIM5alpha with human immunodeficiency virus type 1 infection
    • Speelmon EC, Livingston-Rosanoff D, Li SS, Vu Q, Bui J, et al. (2006) Genetic association of the antiviral restriction factor TRIM5alpha with human immunodeficiency virus type 1 infection. J Virol 80: 2463-2471.
    • (2006) J Virol , vol.80 , pp. 2463-2471
    • Speelmon, E.C.1    Livingston-Rosanoff, D.2    Li, S.S.3    Vu, Q.4    Bui, J.5
  • 42
    • 4644223956 scopus 로고    scopus 로고
    • APOBEC3G genetic variants and their influence on the progression to AIDS
    • An P, Bleiber G, Duggal P, Nelson G, May M, et al. (2004) APOBEC3G genetic variants and their influence on the progression to AIDS. J Virol 78: 11070-11076.
    • (2004) J Virol , vol.78 , pp. 11070-11076
    • An, P.1    Bleiber, G.2    Duggal, P.3    Nelson, G.4    May, M.5
  • 43
    • 13444302306 scopus 로고    scopus 로고
    • Interactions between natural killer cells and antibody Fc result in enhanced antibody neutralization of human immunodeficiency virus type 1
    • Forthal DN, Landucci G, Phan TB, Becerra J, (2005) Interactions between natural killer cells and antibody Fc result in enhanced antibody neutralization of human immunodeficiency virus type 1. J Virol 79: 2042-2049.
    • (2005) J Virol , vol.79 , pp. 2042-2049
    • Forthal, D.N.1    Landucci, G.2    Phan, T.B.3    Becerra, J.4
  • 44
    • 0032402307 scopus 로고    scopus 로고
    • Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection
    • Fehniger TA, Herbein G, Yu H, Para MI, Bernstein ZP, et al. (1998) Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection. J Immunol 161: 6433-6438.
    • (1998) J Immunol , vol.161 , pp. 6433-6438
    • Fehniger, T.A.1    Herbein, G.2    Yu, H.3    Para, M.I.4    Bernstein, Z.P.5
  • 45
    • 0032128276 scopus 로고    scopus 로고
    • Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro
    • Oliva A, Kinter AL, Vaccarezza M, Rubbert A, Catanzaro A, et al. (1998) Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. J Clin Invest 102: 223-231.
    • (1998) J Clin Invest , vol.102 , pp. 223-231
    • Oliva, A.1    Kinter, A.L.2    Vaccarezza, M.3    Rubbert, A.4    Catanzaro, A.5
  • 46
    • 79958116766 scopus 로고    scopus 로고
    • Common HIV-1 peptide variants mediate differential binding of KIR3DL1 to HLA-Bw4 molecules
    • Fadda L, O'Connor GM, Kumar S, Piechocka-Trocha A, Gardiner CM, et al. (2011) Common HIV-1 peptide variants mediate differential binding of KIR3DL1 to HLA-Bw4 molecules. J Virol 85: 5970-5974.
    • (2011) J Virol , vol.85 , pp. 5970-5974
    • Fadda, L.1    O'Connor, G.M.2    Kumar, S.3    Piechocka-Trocha, A.4    Gardiner, C.M.5
  • 47
    • 79956158037 scopus 로고    scopus 로고
    • An early HIV mutation within an HLA-B*57-restricted T cell epitope abrogates binding to the killer inhibitory receptor 3DL1
    • Brackenridge S, Evans EJ, Toebes M, Goonetilleke N, Liu MK, et al. (2011) An early HIV mutation within an HLA-B*57-restricted T cell epitope abrogates binding to the killer inhibitory receptor 3DL1. J Virol 85: 5415-5422.
    • (2011) J Virol , vol.85 , pp. 5415-5422
    • Brackenridge, S.1    Evans, E.J.2    Toebes, M.3    Goonetilleke, N.4    Liu, M.K.5
  • 48
    • 33646686040 scopus 로고    scopus 로고
    • HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
    • Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, et al. (2006) HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107: 4781-4789.
    • (2006) Blood , vol.107 , pp. 4781-4789
    • Betts, M.R.1    Nason, M.C.2    West, S.M.3    de Rosa, S.C.4    Migueles, S.A.5
  • 49
    • 78650598765 scopus 로고    scopus 로고
    • The quest for a T cell-based immune correlate of protection against HIV: a story of trials and errors
    • Koup RA, Graham BS, Douek DC, (2011) The quest for a T cell-based immune correlate of protection against HIV: a story of trials and errors. Nat Rev Immunol 11: 65-70.
    • (2011) Nat Rev Immunol , vol.11 , pp. 65-70
    • Koup, R.A.1    Graham, B.S.2    Douek, D.C.3
  • 50
    • 79952213493 scopus 로고    scopus 로고
    • Relationship between Functional Profile of HIV-1 Specific CD8 T Cells and Epitope Variability with the Selection of Escape Mutants in Acute HIV-1 Infection
    • Ferrari G, Korber B, Goonetilleke N, Liu MK, Turnbull EL, et al. (2011) Relationship between Functional Profile of HIV-1 Specific CD8 T Cells and Epitope Variability with the Selection of Escape Mutants in Acute HIV-1 Infection. PLoS Pathog 7: e1001273.
    • (2011) PLoS Pathog , vol.7
    • Ferrari, G.1    Korber, B.2    Goonetilleke, N.3    Liu, M.K.4    Turnbull, E.L.5
  • 51
    • 36549019907 scopus 로고    scopus 로고
    • Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes
    • Alter G, Martin MP, Teigen N, Carr WH, Suscovich TJ, et al. (2007) Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med 204: 3027-3036.
    • (2007) J Exp Med , vol.204 , pp. 3027-3036
    • Alter, G.1    Martin, M.P.2    Teigen, N.3    Carr, W.H.4    Suscovich, T.J.5
  • 52
    • 67449101826 scopus 로고    scopus 로고
    • HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection
    • Alter G, Rihn S, Walter K, Nolting A, Martin M, et al. (2009) HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection. J Virol 83: 6798-6805.
    • (2009) J Virol , vol.83 , pp. 6798-6805
    • Alter, G.1    Rihn, S.2    Walter, K.3    Nolting, A.4    Martin, M.5
  • 53
    • 34247612099 scopus 로고    scopus 로고
    • Synergy or independence? Deciphering the interaction of HLA Class I and NK cell KIR alleles in early HIV-1 disease progression
    • Barbour JD, Sriram U, Caillier SJ, Levy JA, Hecht FM, et al. (2007) Synergy or independence? Deciphering the interaction of HLA Class I and NK cell KIR alleles in early HIV-1 disease progression. PLoS Pathog 3: e43.
    • (2007) PLoS Pathog , vol.3
    • Barbour, J.D.1    Sriram, U.2    Caillier, S.J.3    Levy, J.A.4    Hecht, F.M.5
  • 54
    • 43249104251 scopus 로고    scopus 로고
    • Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection
    • Long BR, Ndhlovu LC, Oksenberg JR, Lanier LL, Hecht FM, et al. (2008) Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection. J Virol 82: 4785-4792.
    • (2008) J Virol , vol.82 , pp. 4785-4792
    • Long, B.R.1    Ndhlovu, L.C.2    Oksenberg, J.R.3    Lanier, L.L.4    Hecht, F.M.5
  • 55
    • 43149099234 scopus 로고    scopus 로고
    • Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals
    • Boulet S, Sharafi S, Simic N, Bruneau J, Routy JP, et al. (2008) Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals. AIDS 22: 595-599.
    • (2008) AIDS , vol.22 , pp. 595-599
    • Boulet, S.1    Sharafi, S.2    Simic, N.3    Bruneau, J.4    Routy, J.P.5
  • 58
    • 33748490904 scopus 로고    scopus 로고
    • Rhesus macaque polyclonal and monoclonal antibodies inhibit simian immunodeficiency virus in the presence of human or autologous rhesus effector cells
    • Forthal DN, Landucci G, Cole KS, Marthas M, Becerra JC, et al. (2006) Rhesus macaque polyclonal and monoclonal antibodies inhibit simian immunodeficiency virus in the presence of human or autologous rhesus effector cells. J Virol 80: 9217-9225.
    • (2006) J Virol , vol.80 , pp. 9217-9225
    • Forthal, D.N.1    Landucci, G.2    Cole, K.S.3    Marthas, M.4    Becerra, J.C.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.